GE Healthcare has identified radiopharmaceuticals as a growth driver for the company and Japan as a key market.

GEヘルスケア・ジャパンの若林正基代表取締役社長兼CEOは，2023年にGEからGE ...

複雑な財務データから、簡潔で、行動に移せる投資の知見を抽出したヒント。 すべての6を明らかにしましょう 11人のアナリストが来期の売上予測を下方修正した GE HealthCareの株価は本日81.90です どの株式取引所でGE HealthCare株は取引されていますか？

The Chicago-based medical device and technology giant plans to purchase the remaining 50% stake in Nihon Medi-Physics.

Physics, maker of diagnostic radiopharmaceuticals and molecular imaging agents. | GE HealthCare plans to take full control of ...

NMP's product range includes GE HealthCare radiopharmaceuticals, which are essential for imaging in cardiology, oncology, and ...

The manufacturer, which has major operations in Waukesha and Milwaukee counties, aims to grow development of AI devices from ...

GE also rolled out AI for specific imaging tools like X-ray machines. The company said its Critical Care Suite, which is ...

GE HealthCare (Nasdaq: GEHC) has agreed to acquire full ownership of Nihon Medi-Physics Co., Ltd (NMP), by purchasing from ...

GE HealthCare will acquire the remaining 50% stake in Nihon Medi-Physics, enabling it to fully own the Japanese ...

GE HealthCare Technologies is a buy with strong growth prospects, backed by innovative products and improving margins. Learn ...

Axial3D announced a formal collaboration with GE HealthCare to enhance MRI with 3D ... Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and ...